PYXIS ONCOLOGY INC. - COMMON STOCK

Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201

19 ديسمبر 2024 16:08:10 بحسب Nasdaq GlobeNewswire

Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data

20 نوفمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024

12 نوفمبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201

11 نوفمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology to Participate in Two Upcoming Investor Conferences

29 أغسطس 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024

14 أغسطس 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference

29 يوليو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

28 يونيو 2024 16:30:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger

10 يونيو 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference

30 مايو 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024

14 مايو 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference

09 مايو 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

28 مارس 2024 16:30:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights

27 مارس 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023

21 مارس 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA

13 مارس 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024

07 مارس 2024 16:30:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting

05 مارس 2024 16:45:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology Announces $50 Million Private Placement

27 فبراير 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

29 ديسمبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire